[Federal Register Volume 66, Number 46 (Thursday, March 8, 2001)]
[Rules and Regulations]
[Pages 13847-13848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5682]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 510


New Animal Drugs; Change of Sponsor's Name and Address

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect a change of sponsor's name and address for 
Moorman Manufacturing Co.

DATES: This rule is effective March 8, 2001.

FOR FURTHER INFORMATION CONTACT: Norman J. Turner, Center for 
Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-827-0214.

SUPPLEMENTARY INFORMATION: Moorman Manufacturing Co., Quincy, IL 62301, 
has informed FDA of a change of name and address to MoorMan's, Inc., 
1000 North 30th St., Quincy, IL 62305-3115. Accordingly, the agency is 
amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect 
the changes.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is 
amended as follows:

PART 510--NEW ANIMAL DRUGS

    1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


    2. Section 510.600 is amended in the table in paragraph (c)(1) by 
removing the entry for ``Moorman Manufacturing Co.'' and adding a new 
entry in alphabetical order and in the table in paragraph (c)(2) by 
revising the entry for ``021930'' to read as follows:


Sec. 510.600  Names, addresses, and drug labeler codes of sponsors of 
approved applications.

* * * * *
    (c) * * *
    (1) * * *

 
----------------------------------------------------------------------------------------------------------------
                    Firm name and address                                      Drug labeler code
----------------------------------------------------------------------------------------------------------------
 
*                  *                  *                  *                  *                  *
                                                        *
MoorMan's, Inc., 1000 North 30th St., Quincy, IL 62305-3115                         021930
*                  *                  *                  *                  *                  *
                                                        *
----------------------------------------------------------------------------------------------------------------

    (2) * * *

 
----------------------------------------------------------------------------------------------------------------
                 Drug labeler code                                      Firm name and address
----------------------------------------------------------------------------------------------------------------
 
*                  *                  *                  *                  *                  *
                                                        *
021930                                              MoorMan's, Inc., 1000 North 30th St., Quincy, IL 62305-3115
*                  *                  *                  *                  *                  *
                                                        *
----------------------------------------------------------------------------------------------------------------



[[Page 13848]]

    Dated: February 8, 2001.
Claire M. Lathers,
Director, Office of New Animal Drug Evaluation, Center for Veterinary 
Medicine.
[FR Doc. 01-5682 Filed 3-7-01; 8:45 am]
BILLING CODE 4160-01-F